login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
GUARDANT HEALTH INC (GH) Stock News
USA
- NASDAQ:GH -
US40131M1099
-
Common Stock
97.71
USD
-0.21 (-0.21%)
Last: 11/11/2025, 6:27:51 PM
97.71
USD
0 (0%)
After Hours:
11/11/2025, 6:27:51 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
GH Latest News, Press Relases and Analysis
All
Press Releases
12 days ago - By: Chartmill
- Mentions:
FMC
FMFC
EBS
HBIO
...
Here are the top movers in Thursday's session.
12 days ago - By: Chartmill
- Mentions:
FMC
FMFC
EBS
IART
...
The market is filled with gapping stocks in Thursday's session.
2 days ago - By: Guardant Health, Inc.
Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring
5 days ago - By: Guardant Health, Inc.
Guardant Health to Participate in Upcoming Investor Conferences
5 days ago - By: Guardant Health, Inc.
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6 days ago - By: Guardant Health, Inc.
New Study Validates Guardant Reveal Blood Test’s Effectiveness in Monitoring Chemotherapy Response
6 days ago - By: Guardant Health, Inc.
Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients
6 days ago - By: Benzinga
- Mentions:
AMGN
GILD
TEVA
PFE
...
10 Health Care Stocks Whale Activity In Today's Session
7 days ago - By: Guardant Health, Inc.
Guardant Health Announces Pricing of Upsized Public Offering of Common Stock
7 days ago - By: Guardant Health, Inc.
Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering
7 days ago - By: Guardant Health, Inc.
Guardant Health Announces Proposed Public Offering of Common Stock
7 days ago - By: Guardant Health, Inc.
Guardant Health Announces Proposed $300.0 Million Offering of Convertible Senior Notes Due 2033
12 days ago - By: The Motley Fool
Why Guardant Health Was Such an Investor Darling This Week
12 days ago - By: The Motley Fool
- Mentions:
DGX
Why Guardant Health Stock Surged Today
12 days ago - By: Chartmill
- Mentions:
FMC
WOLF
CMG
HBIO
...
Get insights into the top gainers and losers of Thursday's pre-market session.
13 days ago - By: Stocktwits
Guardant Health Stock Soars 21% After-Hours As Strong Q3, Raised Guidance Spark Retail Frenzy
13 days ago - By: Zacks Investment Research
Guardant Health (GH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
13 days ago - By: Zacks Investment Research
- Mentions:
GYRE
Guardant Health (GH) Reports Q3 Loss, Beats Revenue Estimates
13 days ago - By: Chartmill
- Mentions:
FMC
EBS
WOLF
CMG
...
What's going on in today's after hours session
13 days ago - By: Investor's Business Daily
Why IBD 50's Guardant Health, Up 137% in 2025, Could Surge Again
13 days ago - By: Guardant Health, Inc.
Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
14 days ago - By: Benzinga
- Mentions:
CGO
ROL
ESRT
NNBR
...
Earnings Scheduled For October 29, 2025
15 days ago - By: Zacks Investment Research
- Mentions:
GEHC
TEM
Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals
Please enable JavaScript to continue using this application.